Comparing Old and New Drugs for AFib in People Age 65+

When it comes to preventing stroke, millions of Americans with irregular heartbeats (atrial fibrilation or AFib) face a choice: Take one of the powerful but pricey new pills they see advertised on TV, or a much cheaper 60-year-old drug that can be a hassle to take, and doesn’t prevent stroke as well. It doesn’t seem… Continue reading Comparing Old and New Drugs for AFib in People Age 65+

Off-label Use of Device to Prevent Stroke in A-fib Patients Can Be Fatal

The Lariat device, which has been cleared by the U.S. Food and Drug Administration (FDA) for soft tissue approximation (placement of a suture) during surgical procedures, is associated with a significant incidence of death and urgent cardiac surgery during its frequent off-label use to prevent stroke in patients with the irregular heartbeat known as atrial… Continue reading Off-label Use of Device to Prevent Stroke in A-fib Patients Can Be Fatal